- CA$3.92m
- CA$4.56m
- CA$0.00m
- 51
- 72
- 38
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.03 | 0 | 0.006 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.011 | -0.017 | 0.006 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.433 | 0.528 | 0.526 | 0.584 | 2.29 |
Operating Profit | -0.403 | -0.528 | -0.52 | -0.584 | -2.29 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.37 | 12.1 | 0.775 | -7.35 | -4.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.79 | 11.2 | 1.08 | -6.07 | -5.09 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.79 | 11.2 | 1.08 | -6.07 | -5.09 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.79 | 11.2 | 1.08 | -6.07 | -5.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.058 | 0.165 | 0.011 | -0.062 | -0.041 |
Dividends per Share |